Page last updated: 2024-10-19

kynurenine and African Sleeping Sickness

kynurenine has been researched along with African Sleeping Sickness in 2 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Research Excerpts

ExcerptRelevanceReference
"Human African trypanosomiasis, or sleeping sickness, is caused by the protozoan parasites Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense, and is a major cause of systemic and neurological disability throughout sub-Saharan Africa."1.35Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. ( Barrett, MP; Bradley, B; Kennedy, PG; Rodgers, J; Stone, TW, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sternberg, JM1
Forrest, CM1
Dalton, RN1
Turner, C1
Rodgers, J2
Stone, TW2
Kennedy, PGE1
Barrett, MP1
Bradley, B1
Kennedy, PG1

Other Studies

2 other studies available for kynurenine and African Sleeping Sickness

ArticleYear
Kynurenine Pathway Activation in Human African Trypanosomiasis.
    The Journal of infectious diseases, 2017, 03-01, Volume: 215, Issue:5

    Topics: Adolescent; Adult; Aged; Biomarkers; Central Nervous System; Female; Humans; Inflammation; Interfero

2017
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
    Brain : a journal of neurology, 2009, Volume: 132, Issue:Pt 5

    Topics: Animals; Blood-Brain Barrier; Central Nervous System Protozoal Infections; Female; Inhibitory Concen

2009